Farhad Islami Gomeshtapeh, MD, PhD
Strategic Director, Cancer Surveillance Research
Farhad Islami, MD PhD, Strategic Director of Cancer Surveillance Research, joined the American Cancer Society (ACS) in 2014. His work is mainly on monitoring and describing trends in cancer incidence, mortality, and survival rates in the United States and worldwide by sociodemographic factors to measure progress against cancer and to formulate etiologic hypotheses. He also conducts and collaborates on research focused on cancer disparities and cancer risk factors, in particular tobacco smoking.
Dr. Islami earned a M.D. from Tehran University of Medical Sciences in 1994, and a Ph.D. in Epidemiology from King’s College London in 2010. He completed a post-doctoral fellowship in the International Agency for Research on Cancer (the cancer research agency of the World Health Organization), in Lyon, France. He was a faculty member at the Icahn School of Medicine at Mount Sinai, New York, before joining ACS. Dr. Islami is the author or coauthor of more than 110 articles published in peer reviewed journals, several book chapters, and the Tobacco Atlas, 5th Edition.
Islami F, Dikshit R, Mallath MK, Jemal A. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India. Cancer Epidemiology. 2016 Feb;40:79-86.
Islami F, Lortet-Tieulent J, Okello C, Adoubi I, Mbalawa CG, Ward EM, Parkin DM, Jemal A. Tumor size and stage of breast cancer in Côte d'Ivoire and Republic of Congo - Results from population-based cancer registries. Breast. 2015 Dec;24(6):713-7.
Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, Boffetta P, Weiss M. Breastfeeding and breast cancer risk by receptor status-a systematic review and meta-analysis. Annals of Oncology. 2015 Dec;26(12):2398-407.
Islami F, Stoklosa M, Drope J, Jemal A. Global and regional patterns of tobacco smoking and tobacco control policies. European Urology Focus. Aug;1(1):3-16.
Islami F, Ward EM, Jacobs EJ, Ma J, Goding Sauer A, Lortet-Tieulent J, Jemal A. Potentially preventable premature lung cancer deaths in the USA if overall population rates were reduced to those of educated whites in lower-risk states. Cancer Causes & Control. 2015 Mar;26(3):409-18.
Kamangar F, Shakeri R, Malekzadeh R, Islami F. Opium use: an emerging risk factor for cancer? Lancet Oncology. 2014 Feb;15(2):e69-77.